Objective: Abnormal placentation is a serious complication of pregnancy, and is associated with significant morbidity and mortality. There has been recent debate regarding the deployment of occlusive balloons as an adjuvant to surgery to minimize blood loss in these patients. This article reviews the literature on the use of occlusive balloons for management of placenta accreta and outlines some proposals for future management that may improve outcomes. Design: This is a review of published literature regarding endovascular approaches to minimizing hemorrhage during cesarean,delivery in patients with placenta accreta, increta, and percreta. Materials and Methods: Articles published in the English language between 1995 and 2011 regarding the surgical extirpative or conservative approach to placenta accreta, increta, and percreta were reviewed using the search engine, MEDLINE Ò. Key words used were abnormal placentation, internal iliac occlusive balloons, placenta accreta, and uterine embolization. Articles were analyzed for patient demographics, site of balloon occlusion, estimated blood loss, volume of blood transfused, length of hospital stay, and complications. Results: Nineteen publications that described 57 patients were included in the review. Five additional comparative studies were also found and reviewed separately. Most studies deployed the intravascular balloon in the internal iliac artery, whereas others deployed the balloon in the common iliac artery and even the infrarenal aorta. Conclusions: The results of this review support the clinical utility of endovascular devices, but also disclosed significant variability among the published reports. Future multicenter studies should be completed in centralized locations of care, with a selected number of operating obstetricians and efficient teams.